Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2016 Jan 28;11(1):e0148154. doi: 10.1371/journal.pone.0148154

Correction: Targeted Next-Generation Sequencing for Clinical Diagnosis of 561 Mendelian Diseases

Yanqiu Liu, Xiaoming Wei, Xiangdong Kong, Xueqin Guo, Yan Sun, Jianfen Man, Lique Du, Hui Zhu, Zelan Qu, Ping Tian, Bing Mao, Yun Yang
PMCID: PMC4731064  PMID: 26820312

S3, S4 and S5 Tables appear incorrectly in the published article. Please see the correct tables below.

Supporting Information

S3 Table. The list of 561 Mendelian diseases.

(XLSX)

S4 Table. Results of normalization analysis of three patients (P88, P89 and P90).

We detected a microduplication of chromosome 10 in patient P88, the gender ratio was about 1.42. We detected a microduplication of chromosome 9 in patient P89, the gender ratio was about 1.31. We detected a microdeletion in chromosome 17 (16773072–20222149) in patient P90, the gender ration was about 0.55.

(DOC)

S5 Table. Primer pairs designed for validation of mutations by Sanger sequencing or real-time PCR.

(DOC)

Reference

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

S3 Table. The list of 561 Mendelian diseases.

(XLSX)

S4 Table. Results of normalization analysis of three patients (P88, P89 and P90).

We detected a microduplication of chromosome 10 in patient P88, the gender ratio was about 1.42. We detected a microduplication of chromosome 9 in patient P89, the gender ratio was about 1.31. We detected a microdeletion in chromosome 17 (16773072–20222149) in patient P90, the gender ration was about 0.55.

(DOC)

S5 Table. Primer pairs designed for validation of mutations by Sanger sequencing or real-time PCR.

(DOC)


Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES